Budapest, Hungary

Eva Poczik

This inventor holds 2 USPTO granted patents. Top assignee: Egis Gyogyszergyar. Active years: 1992-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eva Poczik: Innovator in Pyridine Derivatives

Introduction

Eva Poczik is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of chemistry, particularly in the development of pyridine derivatives. With a total of 2 patents, her work has implications in various applications, showcasing her innovative spirit and expertise.

Latest Patents

Poczik's latest patents include a process for the preparation of 1,4-dihydro-pyridine intermediates. This invention relates to a method for synthesizing dimethyl-1,4-dihydro-2,6-dimethyl-4-(2'-nitro-phenyl)-pyridine-3,5-dicarboxylate. The process involves reacting specific compounds with methyl acetoacetate, demonstrating her proficiency in chemical synthesis. Another patent focuses on the preparation of 1,4-dihydro-pyridine derivatives through various chemical reactions, further emphasizing her expertise in this area.

Career Highlights

Eva Poczik is associated with Egis Gyogyszergyar, a prominent pharmaceutical company. Her role in the company has allowed her to contribute to significant advancements in medicinal chemistry. Her innovative approaches have positioned her as a key figure in her field.

Collaborations

Poczik has collaborated with notable coworkers, including Pal Benko and Daniel Bozsing. These collaborations have likely enriched her research and contributed to her success in developing new chemical processes.

Conclusion

Eva Poczik's contributions to the field of chemistry, particularly in pyridine derivatives, highlight her innovative capabilities. Her patents and work at Egis Gyogyszergyar reflect her commitment to advancing scientific knowledge and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…